3-(3,4-䮐-2(1H)-) Ӣ 3-(3,4-dihydro-1H-isoquinolin-2-ylsulfonyl)benzoic acid ʽ C16H15NO4S 317.36000 |(zh) 317.07200 PSA 83.06000
؛̖(ho) | Ҏ(gu) | (sh) | r(ji) |
---|---|---|---|
Q-0111435 | 100mg |
1
|
ԃr(ji) |
Q-0111435 | 250mg |
1
|
ԃr(ji) |
Q-0111435 | 500mg |
1
|
ԃr(ji) |
Q-0111435 | 1g |
1
|
ԃr(ji) |
Q-0111435 | 5g |
1
|
ԃr(ji) |

3-(3,4-䮐-2(1H)-)
Ӣ 3-(3,4-dihydro-1H-isoquinolin-2-ylsulfonyl)benzoic acid
ʽ C16H15NO4S
317.36000
|(zh) 317.07200
PSA 83.06000
LogP 3.15050
P(gun)a(chn)Ʒ
2--3--5- CAS:124432-70-8
ɳs|(zh)C(}}) CAS:1243308-37-3
RN486 CAS:1242156-23-5
1H--3- CAS:1239363-47-3
(R)-(-)-4-sˮ CAS:123750-60-7
4--3,5-S CAS:123688-59-5
Prulifloxacin CAS:123447-62-1
27--99--9H- CAS:1229603-71-7
h(hun)ϩïF CAS:12260-67-2
B(ti)w/ĩ/Һ
a(chn)أ
(ch)r(sh)g1
棺
;
SңpgӹٷƼ˾

(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|(zh)ָ(bio) | 95%+ |
ܽl | ЙC(j)܄/ˮ |
CAS̖(ho) | N/A |
N/A | |
(ch)l | -20ܹⱣ |
(ch)r(sh)g | 1 |
\(yn)ݔl | Ҝ2 |
a(chn)Sң | pgӹٷƼ˾ |
-
pgӹٷƼ˾ṩ CEP-40783,CAS1437321-24-8 ^N/A N/A Hʹ
-
pgӹٷƼ˾ṩ CEP-40125;RXDX-107,CAS1456608-94-8 ^N/A N/A Hʹã
-
Ӣ 3-(1H-indol-5-yl)prop-2-enoic acid ʽ C11H9NO2 187.19500 |(zh) 187.06300 PSA 53.09000 LogP 2.26570
-
Ӣ 3-(1H-indol-5-yl)prop-2-enoic acid ʽ C11H9NO2 187.19500 |(zh) 187.06300 PSA 53.09000 LogP 2.26570